Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

Brain Pathology

Volumn 6, Issue 3, 1996, Pages 217-223

  Watanabe, Kunihiko ^a,b   Tachibana, Osamu ^a   Sato, Kazufumi ^a   Yonekawa, Yasuhiro ^b   Kleihues, Paul ^a,b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; TUMOR SUPPRESSOR GENE;

EID: 0030017885     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00848.x     Document Type: Article

References (36)

1. Batra SK, Rasheed BKA, Bigner SH, Bigner DD. (1994) Biology of disease Oncogenes and anti-oncogenes in human central nervous system tumors Lab Invest 71: 621-637
2. Bögler O, Huang HJS, Kleihues P, Cavenee WK. (1995) The p53 gene and its role in human brain tumours. Glia 15: 308-327
3. Brùstle O, Ohgaki H, Schmitt HP, Walter GF, Ostertag H, Kleihues P (1992) Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children Association with an activated K-ras gene. Cancer 69: 2385-2392
4. Burger PC, Green SB. (1987) Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617-1625
5. Burger PC Scheithauer BW.(1994) Tumors of the Central Nervous System Armed Forces Institute of Pathology: Washington
6. Collins VP (1993) Amplified genes in human gliomas. Semin Cancer Biol 4: 27-32
7. Daumas Duport C, Scheithauer B, O'Fallon J, Kelly P. (1988) Grading of astrocytomas A simple and reproducible method. Cancer 62. 2152-2165
8. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP. (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51. 2164-2172
9. Hainaut P (1995) The tumor suppressor protein p53. a receptor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 7: 76-82
10. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36. 714-721
11. Hiesiger EM, Hayes RL, Pierz DM, Budzilovich GN. (1993) Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs). J Neurooncol 16: 93-104
12. Hunter SB, Abbott K, Varma VA, Olson JJ, Barnett DW, James CD. (1995) Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J Neuropathol Exp Neurol 54 57-64
13. Hurtt MR, Moossy J, Donovan Peluso M, Locker J. (1992) Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51: 84-90
14. Kleihues P, Burger PC, Scheithauer BW. (1993) The new WHO classification of brain tumours. Brain Pathol 3: 255-268
15. Lang FF, Miller DC, Koslow M, Newcomb EW. (1994) Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81: 427-436
16. Louis DN (1994) The p53 gene and protein in human brain tumors J Neuropathol Exp Neurol 53 11-21
17. Louis DN, Gusella JF (1995) A tiger behind many doors: multiple genetic pathways to maligant glioma. TIG 11: 412-415
18. Louis DN, von Deimling A, Chung RY, Rubio MP, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR (1993) Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52. 31-38
19. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC (1993) A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme Brain Pathol 3 229-235
20. Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P. (1995) Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427: 113-118
21. Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH (1994) Alterations of the TP53 gene in human gliomas. Cancer Res 54 1324-1330
22. Reichel MB, Ohgaki H, Petersen I, Kleihues P. (1994) p53 mutations in primary human lung tumors and their metastases. Mol Carcinog 9 105-109
23. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53. 2736-2739
24. Salmon I, Dewitte O, Pasteels JL, Flament Durand J, Brotchi J, Vereerstraeten P, Kiss R. (1994) Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type J Neurosurg 80. 877-883
25. Scherer HJ. (1940) Cerebral astrocytomas and their derivatives. Am J Cancer 40: 159-198
26. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, Kiessling M. (1994) Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56. 72-77
27. Shugg D, Allen BJ, Blizzard L, Dwyer T, Roder D. (1994) Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 59 765-770
28. Sugawa N, Ekstrand AJ, James CD, Collins VP. (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci U S A 87: 8602-8606
29. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN (1996) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56. 150-153
30. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG (1994) p53 Mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression J Natl Cancer Inst 86: 1011-1017
31. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wiestler OD, Seizinger BR (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 295-301
32. von Deimling A, Louis DN, Wiestler OD (1995) Molecular pathways in the formation of gliomas Glia 15. 328-338
33. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3: 19-26
34. Wikstrand CJ, Stanley SD, Humphrey PA, Pegram CN, Archer GE, Kurpad S, Shibuya M, Bigner DD. (1993) Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas. J Neuroimmunol 46: 165-173
35. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification Proc Natl Acad Sci USA 84 6899-6903
36. Zariwala M, Schmid S, Pfaltz M, Ohgaki H, Kleihues P, Schafer R. (1994) p53 gene mutations in oropharyngeal carcinomas, a comparison of solitary and multiple primary tumours and lymph-node metastases. Int J Cancer 56: 807-811